A detailed history of Caption Management, LLC transactions in Intra Cellular Therapies, Inc. stock. As of the latest transaction made, Caption Management, LLC holds 60,000 shares of ITCI stock, worth $4.4 Million. This represents 0.07% of its overall portfolio holdings.

Number of Shares
60,000
Previous 138,600 56.71%
Holding current value
$4.4 Million
Previous $9.59 Million 57.16%
% of portfolio
0.07%
Previous 0.15%

Shares

14 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 14, 2024

SELL
$64.76 - $79.84 $17.2 Million - $21.3 Million
-266,162 Reduced 99.77%
618 $42,000
Q1 2024

May 15, 2024

BUY
$64.37 - $75.65 $14.6 Million - $17.2 Million
226,783 Added 567.0%
266,780 $18.5 Million
Q4 2023

Feb 14, 2024

BUY
$46.37 - $73.65 $1.85 Million - $2.95 Million
39,997 New
39,997 $2.86 Million
Q4 2022

Feb 14, 2023

BUY
$44.07 - $54.45 $242,385 - $299,475
5,500 Added 82.03%
12,205 $645,000
Q3 2022

Nov 14, 2022

BUY
$42.7 - $59.99 $286,303 - $402,232
6,705 New
6,705 $312,000
Q1 2022

May 13, 2022

SELL
$38.74 - $62.09 $664,158 - $1.06 Million
-17,144 Closed
0 $0
Q4 2021

Feb 11, 2022

SELL
$35.2 - $53.42 $923,472 - $1.4 Million
-26,235 Reduced 60.48%
17,144 $898,000
Q3 2021

Nov 12, 2021

BUY
$28.72 - $42.49 $956,921 - $1.42 Million
33,319 Added 331.2%
43,379 $1.62 Million
Q2 2021

Aug 16, 2021

BUY
$29.3 - $44.5 $66,218 - $100,570
2,260 Added 28.97%
10,060 $411,000
Q1 2021

May 17, 2021

SELL
$30.8 - $39.51 $729,960 - $936,387
-23,700 Reduced 75.24%
7,800 $265,000
Q4 2020

Feb 16, 2021

SELL
$23.34 - $32.22 $657,557 - $907,734
-28,173 Reduced 47.21%
31,500 $1 Million
Q3 2020

Nov 16, 2020

BUY
$17.61 - $31.86 $116,631 - $211,008
6,623 Added 12.48%
59,673 $1.53 Million
Q2 2020

Aug 14, 2020

SELL
$14.35 - $26.64 $386,732 - $717,948
-26,950 Reduced 33.69%
53,050 $1.36 Million
Q1 2019

May 14, 2019

BUY
$10.9 - $14.09 $872,000 - $1.13 Million
80,000 New
80,000 $975,000

Others Institutions Holding ITCI

About Intra-Cellular Therapies, Inc.


  • Ticker ITCI
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 94,401,696
  • Market Cap $6.92B
  • Description
  • Intra-Cellular Therapies, Inc., a biopharmaceutical company, develops novel drugs for the treatment of neuropsychiatric and neurologic diseases by targeting intracellular signaling mechanisms within the central nervous system in the United States. The company offers CAPLYTA for the treatment of schizophrenia in adults. It is also involved in dev...
More about ITCI
Track This Portfolio

Track Caption Management, LLC Portfolio

Follow Caption Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Caption Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Caption Management, LLC with notifications on news.